Which of the following conditions is associated with an INCREASE in the minimum alveolar concentration of a volatile anaesthetic?

Acute dextroamphetamine intoxication increases MAC because it acutely elevates central catecholamine tone, which is the primary neurochemical driver of anaesthetic requirement.

Why acute dextroamphetamine intoxication raises MAC

Minimum alveolar concentration is defined as the alveolar concentration of a volatile anaesthetic at one atmosphere that prevents purposeful movement in response to a surgical skin incision in 50 percent of subjects. It is the standard potency measure, analogous to the ED50 in pharmacology. MAC is not a fixed number for a given agent. It shifts upward or downward depending on physiological and pharmacological variables. The question tests whether the candidate can identify which direction each modifier pushes MAC.

Acute dextroamphetamine intoxication increases MAC because amphetamine causes presynaptic release of norepinephrine and dopamine and blocks their reuptake, producing a surge of central catecholaminergic activity. The catecholamine theory of MAC, supported by animal and human data, holds that higher central catecholamine tone raises the anaesthetic concentration required to suppress movement. Acute cocaine intoxication behaves identically for the same reason. The critical distinction the exam tests is between acute and chronic stimulant exposure. Chronic amphetamine or cocaine use depletes presynaptic catecholamine stores through repeated vesicular release without adequate resynthesis, and this depletion lowers MAC. The same agent can therefore raise or lower MAC depending on whether the exposure is acute or chronic. This bidirectional effect is a recurring theme in anaesthesia pharmacology and appears in multiple entrance examinations.

The magnitude of MAC elevation in acute amphetamine intoxication is not precisely quantified in standard textbooks, but the direction of change is consistent and well established. Harrison's Principles of Internal Medicine notes that sympathomimetic agents increase anaesthetic requirement. Miller's Anaesthesia explicitly lists acute amphetamine and cocaine intoxication among the conditions that increase MAC. The practical implication is that a patient presenting with acute stimulant toxicity may require higher than usual volatile agent concentrations to maintain adequate depth of anaesthesia, and reliance on standard MAC values alone may result in light anaesthesia and intraoperative awareness.

The catecholamine theory and the neurochemical basis of MAC

MAC is determined primarily at the spinal cord level, not the brain. The endpoint, suppression of movement in response to noxious stimulus, is a spinal reflex modulated by descending pathways. Volatile anaesthetics act at multiple sites, but the immobilizing effect relevant to MAC is mediated largely in the spinal cord dorsal horn and motor neuron pools. Central catecholamine levels modulate this system. Norepinephrine released from locus coeruleus projections and from local spinal noradrenergic terminals facilitates motor neuron excitability and nociceptive transmission. When catecholamine tone is high, more anaesthetic is required to suppress the motor response. When catecholamine tone is low, less anaesthetic suffices.

This framework explains several MAC modifiers beyond amphetamines. Clonidine and dexmedetomidine, alpha-2 agonists, reduce norepinephrine release from presynaptic terminals in the locus coeruleus and spinal cord, and this reduction in noradrenergic transmission lowers MAC. The MAC reduction with clonidine is dose dependent and clinically significant; premedication with clonidine reduces the required concentration of volatile agents. Lithium, which depletes neuronal catecholamines by impairing their synthesis and storage, also lowers MAC. Reserpine, which irreversibly depletes vesicular catecholamine stores, profoundly reduces MAC. These agents all converge on the same neurochemical pathway.

Hyperthermia above 42 degrees Celsius increases MAC, possibly through increased metabolic rate and catecholamine release. Hypothermia reduces MAC progressively, by approximately 5 percent per degree Celsius drop in core temperature, and MAC approaches zero near 20 degrees Celsius. The mechanism is reduced metabolic demand and altered neuronal excitability rather than a direct catecholamine effect, but the clinical consequence is the same: less anaesthetic is needed. Hypernatremia increases MAC, and hyponatremia decreases it, though the mechanism is less clearly tied to catecholamines and may involve altered neuronal membrane potential.

Clinical modifiers of MAC and their magnitudes

The table below summarises the major conditions that alter MAC, their direction of change, and the approximate magnitude where known. This is high yield for NEET PG, INI-CET, and FMGE because questions frequently present a list of conditions and ask which one increases or decreases MAC.

Pregnancy deserves specific comment because it is a commonly tested distractor. The reduction in MAC during pregnancy is attributed to elevated progesterone levels, which potentiate GABA-A receptor function, and to increased endogenous opioid activity. The effect is present from the first trimester and is maximal at term. This is why parturients require lower concentrations of volatile agents and are at higher risk of awareness if standard MAC values are used without adjustment.

How this topic is asked in postgraduate entrance examinations

MAC modifier questions appear in two formats. The first format, used in this question, lists four conditions and asks which one increases MAC. The candidate must know the direction of change for each option. The second format asks which of several listed conditions does NOT increase MAC, or which condition decreases MAC. Both formats test the same knowledge base but require the candidate to hold the entire table of modifiers in working memory.

The most common trap is confusing acute and chronic stimulant exposure. A well-prepared student knows that amphetamines affect catecholamines but may not have registered that acute and chronic exposure have opposite effects on MAC. The exam exploits this gap. Another trap is assuming that all sympathomimetic states increase MAC. Hypotension and severe hypovolemia actually decrease MAC through CNS depression, even though they trigger reflex sympathetic activation. The net effect on MAC is determined by the balance between catecholamine tone and the depressant effect of reduced cerebral perfusion.

Clonidine is a frequent distractor because students associate it with anaesthesia and may assume it is neutral or that it increases MAC by causing sedation. The correct reasoning is that clonidine reduces MAC by reducing noradrenergic transmission, not merely by sedating the patient. Sedation and MAC reduction are related but distinct; a sedated patient still requires a certain alveolar concentration to prevent movement, and clonidine lowers that concentration.

Hypothermia at 34 degrees Celsius is a moderate hypothermia that clearly reduces MAC. The student who confuses hypothermia with hyperthermia will select option A incorrectly. The direction is unambiguous: hypothermia reduces MAC, hyperthermia above 42 degrees increases it. Between 37 and 42 degrees Celsius, the relationship is less steep, but the extremes are well defined.

The single most useful exam strategy is to memorise the short list of conditions that increase MAC, because the list is short and the distractors are numerous. The conditions that increase MAC are: acute amphetamine or cocaine intoxication, hyperthermia above 42 degrees Celsius, hypernatremia, and chronic alcohol use. Everything else on the standard list either decreases MAC or has no significant effect. This inversion, memorising the exceptions rather than the rule, is efficient for examination purposes.

Why the other options fail

One-glance recall table

What the exam actually asks

• Memorise the short list of MAC increasers: acute amphetamine or cocaine intoxication, hyperthermia above 42 degrees Celsius, hypernatremia, chronic alcohol use. Everything else on the standard list decreases MAC or is neutral.
• The acute versus chronic stimulant distinction is the single most tested nuance. Acute exposure raises MAC through catecholamine release. Chronic exposure lowers MAC through catecholamine depletion.
• Clonidine, dexmedetomidine, and other alpha-2 agonists reduce MAC. Do not confuse their sedative effect with MAC neutrality.
• Hypothermia reduces MAC progressively. Hyperthermia increases MAC only above 42 degrees Celsius. The threshold of 42 degrees is the key number.
• Pregnancy reduces MAC by 30 to 40 percent. This is tested as a distractor in questions asking for MAC increasers.

Traps that cost marks

• Selecting hypothermia as a MAC increaser by confusing it with hyperthermia. The direction is opposite: hypothermia reduces MAC, and only hyperthermia above 42 degrees increases it.
• Assuming chronic amphetamine use increases MAC. Chronic use depletes catecholamine stores and lowers MAC. Only acute intoxication increases MAC.
• Assuming clonidine is MAC-neutral because it is used as a premedicant. Clonidine is a potent MAC reducer through alpha-2 mediated reduction in noradrenergic transmission.
• Assuming pregnancy increases MAC because of increased metabolic demand. Pregnancy reduces MAC by 30 to 40 percent through progesterone and endogenous opioid mechanisms.

Frequently asked

Does chronic amphetamine use increase or decrease MAC?

Chronic amphetamine use decreases MAC. Repeated amphetamine exposure depletes presynaptic stores of norepinephrine and dopamine because vesicular release outpaces resynthesis. This catecholamine depletion reduces central noradrenergic tone, which lowers the anaesthetic concentration required to suppress movement. The effect is the opposite of acute amphetamine intoxication, which increases MAC through acute catecholamine release. This acute versus chronic distinction is a recurring examination theme.

Why does clonidine reduce MAC?

Clonidine reduces MAC by activating presynaptic alpha-2 adrenergic receptors in the locus coeruleus and spinal cord. This activation inhibits norepinephrine release, reducing central noradrenergic transmission. Since higher noradrenergic tone raises MAC, reducing it lowers MAC. The effect is dose dependent; clinical premedication doses of clonidine reduce the required volatile anaesthetic concentration by 30 to 50 percent. Dexmedetomidine, a more selective alpha-2 agonist, produces a similar MAC reduction.

What is the MAC reduction in pregnancy?

Pregnancy reduces MAC by approximately 30 to 40 percent at term. The reduction is present from the first trimester and is attributed to elevated progesterone levels, which potentiate GABA-A receptor function, and to increased endogenous opioid activity. This means parturients require lower concentrations of volatile anaesthetic agents, and failure to adjust dosing increases the risk of relative overdose or, conversely, awareness if standard MAC values are used without accounting for the reduction.

References

• Miller's Anaesthesia, 9th. Inhalational anaesthetics: mechanisms of action and MAC modifiers
• Harrison's Principles of Internal Medicine, 21st. Sympathomimetic agents and anaesthetic pharmacology
• Katzung's Basic and Clinical Pharmacology, 15th. Inhalational anaesthetics and factors modifying MAC
• Ganong's Review of Medical Physiology, 26th. Locus coeruleus, noradrenergic transmission, and anaesthetic mechanisms